Description
Proposal for a sublineage of BA.5.2.
Earliest seq: 2022-10-05 (Guangdong, China)
Countries detected: Singapore (16, including 9 travellers from China and 2 travellers from Hong Kong), China (7, all from Guangdong), Cambodia (1), England (1, yet to be uploaded to GISAID)
Mutations on top of BA.5.2:
G12310A, ORF1b:T1050N, C27012T, C27513T (the main branch of BA.5.2+ORF1b:T1050N)
then C2710T, then C8626T, then C16887T+T17208C (note C16887T is extremely homoplasic so doesn't show up on Usher)
GISAID query: nuc mutations C2710T, C8626T, T17208C
This is one of two major lineages that appear to be circulating in China, along with the BF.7 lineage in #1470. Like that lineage, it was present in China long before the end of the zero-Covid policy and therefore appears to be growing as the result of a founder effect. ORF1b:T1050N is the only AA mutation that distinguishes this from BA.5.2, but as BA.5.2+ORF1b:T1050N was never designated, I believe this lineage should still be eligible for designation.
The majority of the sequences in this lineage also have C11824T. Due to a single sequence from Japan on the C2710T+C8626T branch containing this mutation, along with the masking of C16887T, Usher has split the lineage into two separate branches on the tree, one with C11824T and one without. It's pretty clear that Usher has got this wrong.
Usher tree for sequences with C11824T:
Usher tree for sequences without C11824T:
EPI_ISLs
EPI_ISL_16181562
EPI_ISL_16181568
EPI_ISL_16259461
EPI_ISL_16259462
EPI_ISL_16259465
EPI_ISL_16259469
EPI_ISL_16259474
EPI_ISL_16259475
EPI_ISL_16259477
EPI_ISL_16259479
EPI_ISL_16259481
EPI_ISL_16259483
EPI_ISL_16259489
EPI_ISL_16259494
EPI_ISL_16259504
EPI_ISL_16259506
EPI_ISL_16264215
EPI_ISL_16264216
EPI_ISL_16264219
EPI_ISL_16264220
EPI_ISL_16264221
EPI_ISL_16264222
EPI_ISL_16264223
EPI_ISL_16274001